Release Date: October 31, 2025
Expiration Date: October 31, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in neuromuscular disease, with a focus on Duchenne muscular dystrophy (DMD). In this educational program, these experts address unmet needs in DMD, focusing on developing an understanding of the underlying pathophysiological pathways and emerging pharmacological strategies. The importance of an individualized, multidisciplinary approach in managing comorbidities, coordinating care within the health care team, and educating patients and caregivers is also addressed.
This educational activity is an archive of the live symposium held on September 27, 2025.
Target Audience
This educational activity is directed toward neuromuscular disease specialists, neurologists, specialty nurse practitioners, specialty physician assistants, nurses, and other health care practitioners involved in the care of patients with neuromuscular disorders.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Identify the role of dystrophin disruption in the pathophysiology of Duchenne muscular dystrophy
- Evaluate clinical trial data for new and investigational agents for Duchenne muscular dystrophy
- Design multidisciplinary treatment plans for patients with Duchenne muscular dystrophy
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here